297 related articles for article (PubMed ID: 29854832)
1. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
Barros MR; de Oliveira THA; de Melo CML; Venuti A; de Freitas AC
J Immunol Res; 2018; 2018():2912671. PubMed ID: 29854832
[TBL] [Abstract][Full Text] [Related]
2. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
Qi SY; Yang MM; Li CY; Yu K; Deng SL
Front Immunol; 2024; 15():1407649. PubMed ID: 38812510
[TBL] [Abstract][Full Text] [Related]
3. hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
de Freitas AC; de Oliveira THA; Barros MR; Venuti A
J Exp Clin Cancer Res; 2017 May; 36(1):71. PubMed ID: 28545552
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptors in human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
[TBL] [Abstract][Full Text] [Related]
5. Activities of stromal and immune cells in HPV-related cancers.
Barros MR; de Melo CML; Barros MLCMGR; de Cássia Pereira de Lima R; de Freitas AC; Venuti A
J Exp Clin Cancer Res; 2018 Jul; 37(1):137. PubMed ID: 29976244
[TBL] [Abstract][Full Text] [Related]
6. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers.
Bahramabadi R; Dabiri S; Iranpour M; Kazemi Arababadi M
Viral Immunol; 2019 Dec; 32(10):417-423. PubMed ID: 31721657
[TBL] [Abstract][Full Text] [Related]
7. The role of inflammation in HPV carcinogenesis.
Boccardo E; Lepique AP; Villa LL
Carcinogenesis; 2010 Nov; 31(11):1905-12. PubMed ID: 20819779
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study.
Aggarwal R; Misra S; Guleria C; Suri V; Mangat N; Sharma M; Nijhawan R; Minz R
Gynecol Oncol; 2015 Aug; 138(2):358-62. PubMed ID: 26024767
[TBL] [Abstract][Full Text] [Related]
9. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.
Smola S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28895886
[TBL] [Abstract][Full Text] [Related]
11. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
Sasagawa T; Takagi H; Makinoda S
J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
[TBL] [Abstract][Full Text] [Related]
12. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.
Amador-Molina A; Hernández-Valencia JF; Lamoyi E; Contreras-Paredes A; Lizano M
Viruses; 2013 Oct; 5(11):2624-42. PubMed ID: 24169630
[TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
[TBL] [Abstract][Full Text] [Related]
14. Host responses to infection with human papillomavirus.
Stanley MA; Sterling JC
Curr Probl Dermatol; 2014; 45():58-74. PubMed ID: 24643178
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases.
Patra MC; Shah M; Choi S
Semin Cancer Biol; 2020 Aug; 64():61-82. PubMed ID: 31054927
[TBL] [Abstract][Full Text] [Related]
16. HPV modulation of host immune responses.
Feller L; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
SADJ; 2010 Jul; 65(6):266-8. PubMed ID: 20879650
[TBL] [Abstract][Full Text] [Related]
17. The role of regulatory T cells in pathogenesis and therapy of human papillomavirus-related diseases, especially in cancer.
Ao C; Zeng K
Infect Genet Evol; 2018 Nov; 65():406-413. PubMed ID: 30172014
[TBL] [Abstract][Full Text] [Related]
18. Targeting Toll-Like Receptors for Cancer Therapy.
Braunstein MJ; Kucharczyk J; Adams S
Target Oncol; 2018 Oct; 13(5):583-598. PubMed ID: 30229471
[TBL] [Abstract][Full Text] [Related]
19. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review.
Cobos C; Figueroa JA; Mirandola L; Colombo M; Summers G; Figueroa A; Aulakh A; Konala V; Verma R; Riaz J; Wade R; Saadeh C; Rahman RL; Pandey A; Radhi S; Nguyen DD; Jenkins M; Chiriva-Internati M; Cobos E
Int Rev Immunol; 2014 Oct; 33(5):383-401. PubMed ID: 24811210
[TBL] [Abstract][Full Text] [Related]
20. Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy.
Rödel F; Martin D; Balermpas P; Wieland U; Winkelmann R; Riekmann T; Falk S; Rödel C; Fokas E
Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):126-137. PubMed ID: 30605716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
